• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 Vaccess CT Power-Injectable Implantable Port, ChronoFlex, 6F; Port & Catheter, Implanted, Subcutaneous, Intravascular

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 Vaccess CT Power-Injectable Implantable Port, ChronoFlex, 6F; Port & Catheter, Implanted, Subcutaneous, Intravascular Back to Search Results
Catalog Number 7380000
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Bacterial Infection (1735); Unspecified Infection (1930); Sepsis (2067); Bacteremia (4846)
Date of Event 07/13/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported through litigation process that sometime post port placement procedure, the patient allegedly developed infection.However, the current status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through the litigation process that, on (b)(6) 2022, a patient underwent the port placement procedure via the right internal jugular vein for chemotherapy of laryngeal carcinoma.Approximately, five months and twelve days later, on (b)(6) 2022, the patient was diagnosed with bacteremia which was confirmed through blood cultures.Additionally, patient was diagnosed with unspecified infection.Subsequently, the port was removed on (b)(6) 2022.Further, four days later, on (b)(6)2022, patient was diagnosed with vancomycin resistant enterococcal bacterial infection and sepsis due to serratia septicemia.However, the current status of the patient remains unknown.
 
Event or Problem Description
It was reported through the litigation process that, on (b)(6) 2022, a patient underwent the port placement procedure via the right internal jugular vein for chemotherapy of laryngeal carcinoma.Approximately, five months and twelve days later, on (b)(6) 2022, the patient was diagnosed with bacteremia which was confirmed through blood cultures.Additionally, patient was diagnosed with unspecified infection.Subsequently, the port was removed on (b)(6)2022.Further, four days later, on (b)(6)2022, patient was diagnosed with vancomycin resistant enterococcal bacterial infection and sepsis due to serratia septicemia.However, the current status of the patient remains unknown.
 
Additional Manufacturer Narrative
H11: as the lot number for the device was provided, a review of the device history records will be performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.B3, b5, d4 (medical device lot #, unique identifier (udi) #), g3, h6 (patient, result, conclusion).Section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H11: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this lot.Investigation summary: although the physical device was not returned for evaluation, medical records were provided for review.Medical records allege that, the plaintiff was implanted with vaccess ct low profile titanium power injectable port via the right internal jugular vein under the ultrasound guidance for iv access for chemotherapy of laryngeal carcinoma.Entire implantation procedure was done under fluoroscopy.The patient tolerated the procedure well.There were no complications.Approximately, five months and twelve days later, blood cultures were collected and found to be positive for bacteremia.Subsequently, the port was removed two days later, due to bacteremia and infected mediport and picc line was inserted.Catheter was successfully removed from the jugular vein.Subsequently, the subcutaneous reservoir was removed from the surrounding subcutaneous tissue, further, the patient came with the complaint of general weakness after four days.Blood cultures were collected and found to be positive for bacteremia, vancomycin resistant enterococcal bacterial infection, sepsis due to serratia septicemia.Therefore, it can be confirmed that the patient had experienced bacteremia, vancomycin resistant enterococcal bacterial infection, sepsis due to serratia septicemia and infected mediport.However, the relationship to the port is unknown.A review of sterilization records, endotoxin testing results, and bioburden data was conducted in accordance with applicable quality system and regulatory requirements, and no nonconformances or anomalies were identified.Based upon the provided information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.G3, h6 (method, result, conclusion) section a through f: the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Vaccess CT Power-Injectable Implantable Port, ChronoFlex, 6F
Common Device Name
Port & Catheter, Implanted, Subcutaneous, Intravascular
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
Bard Reynosa S.A. de C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
michael gaffney
800 w. rio salado pkwy
tempe, AZ 85281
+1(480)303-2689
MDR Report Key20279271
Report Number3006260740-2024-05418
Device Sequence Number7564356
Product Code LJT
UDI-Device Identifier00801741027451
UDI-Public(01)00801741027451(17)221231(10)REFW5095
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K063377
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/31/2022
Device Catalogue Number7380000
Device Lot NumberREFW5095
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/27/2024
Supplement Date Received by ManufacturerNot provided
09/23/2026
Initial Report FDA Received Date09/23/2024
Supplement Report FDA Received Date09/03/2026
09/25/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
Patient SexFemale
-
-